Related Experiment Video
Updated: Aug 4, 2025

Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
A Standardized, 3-Tiered, Seizure Burden-Based Protocol for the Treatment of Neonatal Seizures
Ashley A Moeller1, Andrei R Stefanescu2, Beatrice M Stefanescu1
1Indiana University School of Medicine, Indianapolis, IN, USA.
Insights
A new protocol for treating neonatal seizures in the neonatal intensive care unit (NICU) reduced midazolam use and electroencephalography (EEG) monitoring duration, improving short-term outcomes.
Area of Science:
- Neonatal Neurology
- Clinical Protocol Development
- Pediatric Epilepsy
Background:
- Neonatal seizures are a common neurological emergency requiring prompt and effective treatment.
- Current treatment protocols vary, potentially leading to suboptimal seizure control and medication side effects.
- Standardizing seizure management is crucial for improving patient outcomes in the neonatal intensive care unit (NICU).
Purpose of the Study:
- To evaluate the effectiveness of a standardized, 3-tiered, seizure burden-based protocol for treating electroencephalography (EEG)-confirmed neonatal seizures.
- To assess the impact of the protocol on short-term outcomes in infants admitted to a level IV NICU.
Main Methods:
- A prospective study design comparing outcomes before and after protocol implementation.
- Enrollment of 107 infants with EEG-confirmed seizures in the NICU over a 25-month period.
- Analysis of medication use (midazolam infusions), EEG monitoring duration, and hospital length of stay.
Main Results:
- Midazolam infusion use decreased by 53.7% (p=0.02) after protocol implementation.
- Duration of EEG monitoring was significantly reduced from 5 to 3 days (p=0.005).
- Hospital length of stay remained unchanged; however, midazolam infusion duration showed a non-significant increase when excluding outliers.
Conclusions:
- Implementation of a standardized, 3-tiered protocol effectively improved short-term outcomes for neonatal seizures.
- Reduced EEG duration and midazolam use suggest a decreased overall seizure burden.
- Further research is warranted to determine the long-term neurodevelopmental effects of this protocol.
Objective:
To evaluate use of a standardized, 3-tiered, seizure burden-based protocol for treatment of all electroencephalography (EEG)-confirmed seizures in a level IV neonatal intensive care unit (NICU).
Study Design:
All infants admitted to the NICU with EEG-confirmed seizures over a 25-month period were enrolled in the study. We compared short-term outcomes before and after implementation of a standardized, 3-tiered protocol.
Results:
A total of 107 infants were enrolled in the study. Use of midazolam infusions was reduced by 53.7% (p = 0.02). Midazolam infusion duration increased from 4 to 7.5 days (p = 0.003); however, when excluding 3 outliers, there was no significant difference between groups (-p = 0.67). Duration of EEG monitoring decreased from 5 to 3 days (p = 0.005). Hospital length of stay was unchanged.
Conclusion:
Implementation of a standardized, 3-tiered protocol for treatment of neonatal seizures improved short-term outcomes. Although not measured directly, reductions in EEG duration and midazolam use are promising indicators of overall seizure burden. More research is needed to evaluate impact on long-term neurodevelopmental outcomes.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

